Riferimento farmaci
Daridorexant
Daridorexant is a medicine in the class central nervous system. It is used for insomnia.
- Classe del farmaco: Central Nervous System
- Indicato per: insomnia
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Central Nervous System
- Codice ATC
- N05CJ03
- Forme farmaceutiche comuni
- compressa
- Interazioni note
- 173 (Maggiore: 12 · Moderata: 146 · Minore: 15)
- Nomi commerciali
- 2
- Paesi e mercati
- 2
Per cosa si usa
Come agisce
Presumed to act through antagonism of orexin receptors; blocking binding of orexin A and orexin B to OX1R and OX2R is thought to suppress wake drive.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Insomnia (sleep onset and/or maintenance): 25 mg to 50 mg orally once per night, within 30 minutes of going to bed, with at least 7 hours remaining before planned awakening.
Gravidanza e allattamento
- Gravidanza
- Unknown No human pregnancy data. In rats and rabbits, doses up to 8-10 times human exposure caused no fetal toxicity or malformations. A US pregnancy registry exists. Prefer non-drug measures for insomnia in pregnancy; use only if clearly needed.
- Allattamento
- Safe Passes into milk in very low amounts (well under 1% of the mother's weight-adjusted dose). LactMed: not a reason to stop breastfeeding. US label: watch the infant for excessive sedation; also check feeding and weight gain.
Effetti indesiderati segnalati
- Headache
- Somnolence or fatigue
- Dizziness
- Nausea
- Nightmares or abnormal dreams (post-marketing)
- Hypersensitivity including angioedema, rash, urticaria (post-marketing)
Controindicazioni
- Narcolepsy.
- History of hypersensitivity to daridorexant or any component of the product; angioedema with pharyngeal involvement has been reported.
Chi deve prestare attenzione
- CNS depressant effects and daytime impairment, which may persist for several days; caution against next-day driving; risk increases with less than a full night of sleep remaining, higher doses, or other CNS depressants; falls risk especially in the elderly.
- Worsening of depression and suicidal ideation; use with caution in patients with depressive symptoms and monitor suicide risk.
- Sleep paralysis, hypnagogic/hypnopompic hallucinations and cataplexy-like symptoms may occur.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (173)
- Amobarbital + Daridorexant Major
- Apalutamide + Daridorexant Major
- Clarithromycin + Daridorexant Major
- Daridorexant + Enzalutamide Major
- Daridorexant + Fluvoxamine Major
- Daridorexant + Itraconazole Major
- Daridorexant + Ketoconazole Major
- Daridorexant + Mifepristone Major
- Daridorexant + Phenytoin Major
- Daridorexant + Posaconazole Major
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Daridorexant: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 7 giorni sul web. Nessuna carta.
Domande frequenti
What is Daridorexant used for?
Daridorexant is a medicine in the class central nervous system. It is used for Insomnia.
What side effects have been reported with Daridorexant?
Headache, Somnolence or fatigue, Dizziness, Nausea, Nightmares or abnormal dreams (post-marketing), Hypersensitivity including angioedema, rash, urticaria (post-marketing).
Can Daridorexant be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human pregnancy data. In rats and rabbits, doses up to 8-10 times human exposure caused no fetal toxicity or malformations. A US pregnancy registry exists. Prefer non-drug measures for insomnia in pregnancy; use only if clearly needed. Breastfeeding: Safe. Passes into milk in very low amounts (well under 1% of the mother's weight-adjusted dose). LactMed: not a reason to stop breastfeeding. US label: watch the infant for excessive sedation; also check feeding and weight gain.
What does Daridorexant interact with?
MediHelp lists 173 known interactions for Daridorexant. Major: 12 · Moderate: 146 · Minor: 15. The most serious include Amobarbital, Apalutamide, Clarithromycin.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
